ÂÜÀòÂÒÂ×

Marcel Keller has a diverse work experience spanning over several years. Marcel started their career in 1993 as a PhD Student at the University of Basel, where they focused on the study of transposable elements and insertion sequences in E. coli. After completing their PhD, Marcel worked as a Postdoctoral Fellow at The Children's Hospital of Philadelphia. Marcel then moved on to the University of Washington, where they held the position of Senior Fellow. In 1999, Marcel joined the University of Basel as a Project Leader. After nine years, they joined Actelion as a Senior Lab Head, where they worked until 2017. Currently, Marcel is employed at Idorsia Pharmaceuticals Ltd, where they hold the position of Principal Scientist and Deputy Head of Immunology Biology.

Marcel Keller earned their Matura degree in Typus B from Gymnasium Oberwil in 1987. Marcel then pursued a Dipl. phil. II in Molecular Biology at Biozentrum, University of Basel from 1987 to 1991. Later, they obtained a PhD in Molecular Genetics from the same institution between 1992 and 1996. Recently, from 2015 to 2017, Marcel Keller completed the European Course in Pharmaceutical Medicine (ECPM) at the University of Basel. Marcel has also obtained a certification in ORCID from ORCID.